Introduction
Haemagglutinin (HA), the major surface glycoprotein of influenza virus, capable of inducing virus-neutralizing antibodies, is subject to frequent, accumulating mutations called antigenic drift (Verhoeyen et al., 1980) . Because of these alterations the virus is able to escape neutralization. HA is a homotrimeric molecule, each monomer consisting of two disulfide-linked glycopolypeptides, HA " and HA # , generated by proteolytic cleavage (Klenk et al., 1975) . HA consists of two structurally distinct domains : a globular head composed of the bulk of HA "
, and a stem structure composed of part of HA " and all of HA # . The β-structure-rich globular of LMBH6 to virus and to virus-infected cells is weak, while binding to BHA is comparable. Electron microscopy demonstrates binding to the membrane proximal end of the stem structure. The antibody shows no haemagglutination-inhibition activity, but inhibits polykaryon formation and the low-pHinduced conformational change of BHA. However, LMBH6 cannot prevent infection of MDCK cells but slows the growth of virus when included in a plaque assay overlay.
head contains the sialic acid receptor-binding pocket surrounded by variable antigenic sites . The major component of the stem is a hairpin-like structure consisting of two antiparallel α-helices of unequal length linked by an extended polypeptide chain. At low pH (5-6), HA undergoes an irreversible conformational change resulting in the loss of the trimeric structure of the globular domain (Skehel et al., 1982 ; Ruigrok et al., 1986) , while extensive refolding or reorganization with preservation of the trimeric structure occurs in the stem structure (Ruigrok et al., 1988 ; Bullough et al., 1994) . These conformational changes result in differences in antigenicity : trimer-specific epitopes are lost, while binding of antibodies recognizing other regions is not affected (Yewdell et al., 1983 ; . New epitopes, specific for the low-pH-induced conformation, are generated as well, especially on the stem region of the HA molecule where the HA # polypeptide is highly conserved among all influenza A viruses (Webster et al., 1983 ; Kostolansky et al., 1988) . Therefore, it is not surprising that inter-and intra-subtype cross-reactivity with HA # -specific antibodies has been demonstrated (Graves et al., 1983 ; Russ et al., 1987) . Several attempts have been made to isolate HA-specific cross-reactive neutralizing monoclonal antibodies (MAbs). So far, the isolation of one anti-HA MAb with high cross-reactivity among H1 and H2 strains has been reported (Okuno et al., 1993 (Okuno et al., , 1994 . Sequencing of antigenic variants demonstrated binding to the stem region of HA, and the epitope contained both HA " and HA # amino acids. The present authors have previously described an antibody recognizing a fairly conserved epitope among H3 strains. This epitope was shown to become inaccessible on the HA due to mutations outside the actual epitope. The MAb selected a virus with a substitution in the ' left side ' of the receptor-binding pocket (Vanlandschoot et al., 1995) . Recently, H3-specific neutralizing MAbs showing some degree of cross-reactivity were isolated from transgenic mice expressing a human immunoglobulin µ minigene. These MAbs selected novel variant viruses with substitutions in both the conserved receptor-binding pocket and an antigenic site (Laeeq et al., 1997) . Here we report the isolation of a trimer-specific crossreactive MAb, recognizing an epitope close to the membrane on the stem structure of H3 HA.
Methods
Viruses. A\Japan\305\57 (H2N2) and recombinant viruses between the WHO reference H3N2 strains A\Aichi\2\68 (X31), A\Victoria\3\75 (X47), A\Philippines\2\82 (X79), A\Beijing\352\89 (NIB26) and A\PR\8\34 (H1N1) were used. These viruses all express surface glycoproteins of the H3N2 subtype. Viruses were grown in the allantoic cavity of 10-day-old embryonated chicken eggs and were purified on a Matrex Cellufine sulphate column according to the manufacturer's instructions (Amicon) or by sucrose gradient sedimentation (Skehel & Schild, 1971) . Purified virus was stored at 4 mC in PBS. Haemagglutination inhibition tests were performed with chicken erythrocytes. To obtain bromelain-cleaved HA (BHA), purified virus was digested with bromelain and purified as described (Brand & Skehel, 1972 ; Vanlandschoot et al., 1993) .
MAbs. MAb IIF4, a gift of F. Kostolansky (Institute of Virology, Bratislava), was raised against A\Dunedin\4\73 (H3N2) and is a crossreactive HA # -specific MAb, reacting with the trimeric form of HA in pH 5 conformation (Russ et al., 1987 ; Kostolansky et al., 1988 ; Vareckova et al., 1993 ; Wharton et al., 1995) . HC59 was prepared against A\Port Chalmers\1\73 but reacts also with A\Victoria\3\75 and binds to both the native and low-pH-induced HA conformation. MAb HC31 is specific for the native A\Aichi\2\68 HA structure, while MAbs HC3 and HC73 recognize both the native and low-pH HA conformation (Daniels et al., 1983 b) . MAb LMBH5 recognizes a fairly conserved epitope on the H3 haemagglutinin near the receptor-binding pocket. LMBH5 recognizes the native structure of A\Victoria\3\75 HA, but binding is enhanced after low-pH treatment (Vanlandschoot et al., 1995) . When used in a sandwich ELISA, it recognizes only the low-pH structure (Vanlandschoot et al., 1998) .
Purification of MAbs.
MAbs HC73 and LMBH6 were purified from ascitic fluid using Protein A-Sepharose 4B (Sigma) and Protein G-Sepharose 4 FF (Pharmacia), respectively, according to the manufacturers ' instructions.
Isolation of MAb LMBH6. BALB\c mice (8-9 weeks old ; Charles River, Sulzfeld, Germany) were immunized intranasally with 5 µg X31 BHA ; 10 days later the mice received a first boost immunization with 5 µg X47 BHA, and after a further 10 days mice received 5 µg X79 BHA. Three days later, and 3 days prior to fusion, mice were boosted with 1 µg BHA of each virus. Splenic lymphocytes were fused with SP2\OAg-14 myeloma cells as described (Kohler & Milstein, 1975) . Hybridoma cell supernatants were screened in ELISA on X31, X47 and X79. Positive cultures were subcloned twice and retested on X31, X47, X79 and NIB26.
ELISA on virus. Maxisorp 96-well plates (Nunc) were coated with purified virus in PBS. To obtain acid-induced HA conformation, the plates were incubated with 50 mM citrate pH 5. After two washings [0n5% Triton X-100 (T-X100) in PBS], plates were blocked with 0n1 % BSA in PBS, followed by two washing steps. Ascitic fluid (1 µg\ml MAb in PBS-0n1 % BSA) was added and the plates were incubated at room temperature for 90 min. After two washings the wells were incubated at room temperature for 90 min with alkaline phosphatase-conjugated goat anti-mouse IgG (Sigma). Substrate solution (1 mg\ml sodium p-nitrophenol in diethanolamine) was added and the absorbance (A) was measured at 405 nm at appropriate times.
ELISA on virus-infected MDCK cells. MDCK cells were grown in microtitre plates and infected at room temperature with 500 haemagglutination units (HAU) of virus. After 1 h the inoculum was removed and cells were washed twice with PBS. After 5 h incubation at 37 mC in serum-free medium, the cells were fixed for 20 min with 1n5% (w\v) paraformaldehyde in PBS ; to obtain the acid-induced HA conformation, cells were first incubated in PBS with 10 µg\ml trypsin (10 min at room temperature), followed by incubation in 50 mM citrate pH 5 for 20 min at room temperature. ELISA was performed as described above.
Sandwich ELISA. Maxisorp 96-well plates were coated with rabbit anti-HA IgG (1 µg\ml in PBS). After two washings (0n05 % T-X100 in PBS), the wells were blocked with 0n1 % BSA in PBS, followed by two washing steps. BHA was added to the wells and the plates were incubated for 1n5 h at room temperature. The low-pH conformation of BHA was induced by treatment with 50 mM citrate pH 5. After 10 min, the solution was neutralized with Tris-HCl pH 7n4. ELISA was performed as described above.
Cell-cell fusion inhibition assay. CHO cells, expressing A\ Aichi\2\68 H3 HA (Godley et al., 1992) , were used for heterokaryon formation. Where appropriate, cells were treated for 10 min with 2n5 µg\ml trypsin in 0n15 M NaCl, 10 mM HEPES, 2 mM CaCl # pH 7n4, to cleave HA ! to HA " and HA # . Cells were incubated for 30 min at 37 mC with MAbs at the concentrations indicated. The pH was decreased to 5 for 1 min, and then the cells were incubated with DMEM containing 5 % foetal calf serum. After 30 min, monolayers were fixed with 0n25 % glutaraldehyde in PBS and stained with 1 % toluidine blue in PBS.
Virus neutralization assay. Virus was mixed with ascitic fluid serially diluted twofold, or with PBS. The mixtures were left to incubate at room temperature for 1 h and then added to MDCK cells grown in microtitre plates. After 1 h the inoculum was removed and the cells incubated for 5 h at 37 mC. ELISA was performed as described above.
Plaque assays to examine resistance or sensitivity to antibody. Sixty µl of X31 (2000 p.f.u.\ml) was mixed with 120 µl antibody (7n5, 32n5 or 75 µg\ml) and incubated for 1 h at room temperature as indicated. MDCK cells, grown in 35 mm dishes, were incubated with the virus-antibody mixtures for 1 h at room temperature.
A cross-reactive HA-specific antibody A cross-reactive HA-specific antibody After removal of the inoculum, 2 ml of overlay medium containing 2n5 µg\ml trypsin was added. Plaque size reduction was investigated by adding antibody to the overlay at the concentrations indicated. Dishes were incubated upside down for 3 days at 37 mC. Cells were fixed in 0n05 % glutaraldehyde and incubated for 30 min with 3 % BSA in PBS. Plaques were visualized by incubating the cells with a mixture of HAspecific MAbs, followed by horseradish peroxidase-conjugated goat antimouse IgG and stained with 0n9 % 4-chloro-1-naphthol, 0n075 % H # O # in PBS.
Low-pH treatment of BHA-antibody complexes and conformational change detection. To 1 µl BHA (600 ng\ml), 6 µl LMBH6, HC73 (3 mg\ml) or PBS was added. Mixtures were incubated for 1 h at room temperature ; 14 µl 50 mM citrate pH 5 was added and the mixtures were incubated for 10 min at 37 mC. The solution was neutralized by adding 4 µl 1 M Tris-HCl pH 8 and left for 10 min at room temperature. To the neutralized mixtures, 5 µl of 60 µg\ml trypsin or 120 mM dithiothreitol (DTT) was added. After incubation for 20 min at room temperature, 10 µl trypsin inhibitor (75 µg\ml) or 500 mM iodoacetamide was added. Mixtures were incubated for 15 min at room temperature. Samples were separated by SDS-PAGE under non-reducing conditions (Laemmli et al., 1970) , followed by immunoblotting.
HC73 F(abh) 2 and Fabh preparation. Purified HC73 (2 mg\ml) was digested with pepsin (60 µg\ml) in 0n15 M sodium citrate buffer pH 4n0 for 4 h at 37 mC (Shahinian & Silvius, 1995) . The reaction was terminated by raising the pH by overnight dialysis against 145 mM NaCl, 10 mM Tris-HCl pH 7n4. Undigested IgG was removed by passage through a 5 ml Protein A-Sepharose column at pH 7n4. Then F(abh) # positive fractions, detected by absorbance at 280 nm, were pooled and concentrated to 5 mg\ml, changing the buffer to 100 mM Tris-HCl pH 7n6 using an Amicon ultrafiltration device (PM10 membrane). All solutions used for Fabh production and liposome coupling were degassed by nitrogen purging. One ml of 5 mg\ml F(abh) # in 100 mM Tris-HCl pH 7n6 was reduced with 30 mM cysteine for 15 min at 37 mC under a nitrogen atmosphere. Cysteine was removed and buffer exchanged by passage through a NAP-10 desalting column (Pharmacia) equilibrated with degassed 100 mM NaCl, 100 mM borate, 50 mM citrate, 2 mM EDTA pH 5n5. Fabh appearing in the void volume was maintained under nitrogen and used immediately in coupling experiments described below.
Preparation of liposomes. N-[3-(2-Pyridyldithio)propionyl]-
phosphatidylethanolamine (PDP-PE) was synthesized as described (Martin et al., 1981) . PDP-PE was purified on a silica gel-60 column (Merck) and stored in chloroform (10 mg\ml) under nitrogen at k20 mC. Then 2n0 mg PDP-PE, 13n5 mg phosphatidylcholine and 7n7 mg cholesterol plus trace amounts of [1α2α(n)-$H]cholesterol were mixed, followed by evaporation under nitrogen of the chloroform and lyophilization. After addition of 5 ml of 100 mM NaCl, 100 mM borate, 50 mM citrate, 2 mM EDTA pH 6n0, small unilamellar liposomes were prepared by a sonication method as described by Wharton et al. (1986) . Multilamellar liposomes and debris were removed by centrifugation at 100 000 g for 30 min at 4 mC.
Attachment of HC73 Fabh fragments to liposomes. One ml of liposome was mixed with 1n5 ml of the HC73 Fabh fragments. The pH was adjusted to 8 with NaOH and the mixture gently stirred under a nitrogen atmosphere at room temperature for 2 h. Uncoupled Fabh was removed by adding an equal volume of 60 % (w\v) sucrose in PBS, and an overlay of 20 % sucrose in PBS was added. Liposomes were recovered on the top of this overlay after centrifugation at 100 000 g for 24 h at 5 mC.
Electron microscopy. Samples were absorbed onto carbon films and negatively stained with 1 % sodium silicotungstate (pH 7n0). Micrographs were taken under minimum dose and accurate defocus conditions to preserve detail to approximately 1n5 nm (Wrigley et al., 1983) . The JEOL 1200 EX microscope was operated at 100 kV and magnification was regularly calibrated with catalase crystals. A graticule eyepiece with i10 additional magnification was used for the length measurements.
Results

Isolation of MAb LMBH6
Two mice were immunized as described by sequential intranasal administration of 5 µg BHA derived from X31, X47 and X79 virus. Three days before fusion, mice received a mixture of 1 µg of each BHA preparation. Serum, taken just before fusion, was tested in ELISA for the presence of HAspecific antibodies. We observed binding of antibodies to the three viruses from which BHA was prepared to immunize the mice, as well as to NIB26 and X121 viruses (data not shown). As the mice were never challenged with BHA derived from the latter two viruses, this binding clearly demonstrated the presence of cross-reactive antibodies. Polyclonal hybridoma cell supernatants were screened in ELISA on X31, X47 and X79. Positive cultures were subcloned twice and retested on X31, X47, X79 and NIB26. One isolated MAb, LMBH6 (IgG1 isotype), was selected for detailed characterization. LMBH6 could not inhibit viral haemagglutination of erythrocytes.
ELISA on purified virus
LMBH6 reacted in ELISA with HA in the neutral conformation of the X31, X47, X79 and NIB26 viruses, while binding was no longer observed after treatment at pH 5, demonstrating that LMBH6 recognized a native-specific epitope (Fig. 1, four upper panels) . LMBH6 did not recognize A\Japan\305\57 (H2N2) and A\PR\8\34 (H1N1) HA (data not shown). Binding of different, well characterized, conformation-specific MAbs to the different HA conformations of the four viruses served as a control. However, compared to these MAbs, binding of LMBH6 seemed to be weak (Fig. 1, four lower panels) .
ELISA on infected cells
Binding of LMBH6 to untreated, trypsin-or low-pHtreated, or trypsin-and low-pH-treated HA was determined in ELISA on infected cells. LMBH6 did recognize uncleaved HA, but binding was enhanced by trypsin treatment (Fig. 2, four upper panels). Trypsin treatment prior to low-pH treatment abolished binding of LMBH6 completely. Again, MAbs HC31, HC59, LMBH5 and IIF4, in combination with X31, X47, X79 and NIB26, respectively, were used as controls (Fig. 2, four  lower panels) . Again, compared with these antibodies, binding of LMBH6 was weak. 
Binding to BHA
Binding of LMBH6 to native and low-pH-treated A\ Victoria BHA was determined in a sandwich ELISA (Table 1) . Binding was compared with HC59, LMBH5 and IIF4. HC59 recognized native and acid-treated BHA equally well. Although we previously demonstrated binding of LMBH5 to native viral HA (Vanlandschoot et al., 1995) , only binding to low-pH-treated BHA was detected. IIF4 recognized only acidtreated BHA, while binding of LMBH6 occurred only to native BHA. Contrary to the weaker binding of LMBH6 to membrane-bound HA, binding to BHA was comparable with the binding of HC59 and LMBH5. Using a recombinant, uncleaved, trimeric HA molecule (A\Aichi\2\68), which can be released from the cell membrane by trypsin treatment (THA ! ) and can be cleaved into HA " and HA # by bromelain [BTHA (kindly provided by David Steinhauer, NIMR) ; unpublished results], the increased binding of LMBH6 to cleaved HA was clearly demonstrated (Table 2) .
Neutralization by LMBH6
X31, X47 and X79 viruses were mixed with LMBH5 or LMBH6 ascitic fluid serially diluted twofold, or with PBS. The mixtures were left to incubate at room temperature for 1 h and then added to MDCK cells grown in microtitre plates. After 1 h the inoculum was removed and the cells incubated for 5 h at 37 mC. ELISA was performed as described. Using this assay, we have previously shown that LMBH5 could prevent X31 and X47 infection of MDCK cells, but not that of X79 (Vanlandschoot et al., 1995) . This neutralizing capacity was slightly less efficient when compared to other MAbs. Here, almost identical results were obtained for LMBH5, as demonstrated by the 50 % inhibition values (20, 30 and 200 µg\ml for X31, X47 and X79, respectively), as reported previously (Vanlandschoot et al., 1995) . LMBH6 could not prevent infection of MDCK cells as demonstrated by the high IV &! values (175, 370 and 120 µg\ml for X31, X47 and X79, respectively) obtained for all three viruses. This lack of neutralization was confirmed in a plaque assay using X31 virus. Even when 50 µg\ml of purified LMBH6 was used, no neutralization was observed (Fig. 3) . However, when the antibody was included in the overlay a reduction in plaque size was observed. A small reduction in size was observed when 5 µg\ml LMBH6 was added to the overlay. A more significant reduction was obtained using 25 µg\ml, while adding 50 µg\ml did not result in further size reduction. No neutralization, nor reduction in size, was observed using an A cross-reactive HA-specific antibody A cross-reactive HA-specific antibody HIV-specific MAb or with A\Japan\305\57 (H2N2) (not shown).
Electron microscopy of BHA-LMBH6 complexes
Due to the lack of neutralization and the large amounts needed to obtain some reduction in plaque size, it was not possible to obtain escape mutants to localize the epitope. Electron microscopy was used to reveal where the antibody binds to HA. The micrographs shown in Fig. 4 (a) contain different images of X31-derived BHA complexed with LMBH6. From these images, it is clear that the MAb binds to one end of BHA and that two MAbs, possibly three, can bind simultaneously to one BHA molecule. Although differently shaped complexes can clearly be distinguished, demonstrating the flexibility of the antibody, binding always occurs at an angle of approximately 110 m. However, these images of BHA-LMBH6 complexes cannot reveal which end of the molecule LMBH6 binds to. This was determined by visualizing Fab (HC73) vesicle-BHA-LMBH6 complexes.
Liposomes containing Fab fragments of a MAb (HC73) recognizing the globular heads were obtained as described. These Fab vesicles were incubated with BHA, followed by incubation with MAb LMBH6. From the electron micrographs shown in Fig. 4 (b) , it is clear that LMBH6 binds to the membrane-proximal end of the stem structure of BHA. Again, binding of two LMBH6 molecules to one BHA molecule is clearly visible.
Inhibition of the low-pH-induced conformational change by LMBH6
For influenza virus, two major antibody-mediated neutralization mechanisms have been described : blocking BHA 0n83 1n70 0n00 0n56 0n00 1n06 0n51 0n05 THA ! 0n98 0n92 0n00 0n11 0n00 0n07 0n04 0n03 BTHA 0n91 1n78 0n00 0n82 0n00 1n49 0n51 0n00 attachment of HA to its cellular receptor, and blocking fusion by interfering with the low-pH-induced conformational change of the HA molecule (Kida et al., 1982 (Kida et al., , 1983 (Kida et al., , 1985 Yoden et al., 1986) . The electron microscopy studies suggest that the epitope is very close to the lipid bilayer and could be rather inaccessible for LMBH6 on membrane-bound HA. This inaccessibility of the epitope is supported by the different binding assays, demonstrating lesser or weaker binding of LMBH6 to membrane-bound HA than to BHA. If, because it binds the stem, LMBH6 could inhibit the low-pH-induced conformational change, as has been suggested for MAb C179 (Okuno et al., 1993) , this inaccessibility might perhaps explain the lack of neutralization observed. Using BHA, we investigated whether LMBH6 has the intrinsic capacity to block the low-pH-induced conformational change. In addition to changes in antigenicity Webster et al., 1983) , the low-pH-induced conformation also becomes susceptible to trypsin at residues HA " 27 and HA " 224 (Skehel et al., 1982) , while DTT treatment can now reduce the single disulfide bond joining the HA " and HA # subunits (Graves et al., 1983) . These two assays were used to determine possible inhibition of the low-pH-induced conformational change. X31 BHA was mixed with LMBH6 or HC73, an antibody which binds to the globular heads. Following pH 5 treatment for 10 min and neutralization, the mixtures were treated with trypsin or DTT. After the addition of trypsin inhibitor or iodoacetamide, respectively, samples were separated by SDS-PAGE under non-reducing conditions, followed by immunoblotting. As shown in Fig. 5 , in the presence of HC73 or in the absence of any antibody, proteolytic degradation and reduction of the disulfide bond are observed ; however, in the presence of LMBH6 the majority of the BHA molecules do not become susceptible to trypsin, nor is the disulfide bond between HA " and HA # reduced, indicating that LMBH6 prevents the conformational change.
Inhibition of cell-cell fusion by LMBH6
Although LMBH6 did not prevent infection of MDCK cells, indicating that fusion was not inhibited, this MAb has the capacity to prevent the low-pH-induced conformational change. We performed a cell-cell fusion inhibition assay to determine whether LMBH6 could inhibit HA-mediated fusion. Fig. 6 (a) shows typical results of a fusion assay in which CHO cells expressing HA were used. Monolayers treated with trypsin, followed by brief (1 min) exposure at pH 5, showed formation of polykaryons. In the presence of 50 µg\ml LMBH6, cell-cell fusion was efficiently inhibited. Partial inhibition was observed using 5 and 0n5 µg\ml. MAb HC3 inhibited cell fusion slightly better than LMBH6, while a neuraminidase-specific MAb (NC82) did not inhibit at all (Fig. 6 b) .
Discussion
During the past 20 years, various MAbs against the HA of different influenza viruses have been isolated. They have been useful tools in studies on variability of influenza viruses, studies on the structure and functions of HA, and investigations into protein folding and secretion pathways in cells. However, the majority of these antibodies recognize those regions on the molecule which are involved in variation and neutralization of viruses. For the HA of the H3 subtype, four of these antigenic regions are situated on the globular heads of the molecule, while one is closer to the stalk Skehel et al., 1984) . Fewer MAbs specific for the more conserved stalk have been isolated, and most of these recognize the low-pH structure (Russ et al., 1987 ; Kostolansky et al., 1988 ; Wharton et al., 1995) or denatured HA (Green et al., 1982 ; Webster et al., 1983 ; Graves et al., 1983 ; Sanchez-Fauqier et al., 1987) . So far, the isolation of only one neutralizing anti-HA MAb, binding to the stem structure and showing high cross-reactivity among H1 and H2 strains, has been reported (Okuno et al., 1993 (Okuno et al., , 1994 . In order to isolate cross-reactive antibodies, we immunized mice sequentially with BHA derived from distantly A cross-reactive HA-specific antibody A cross-reactive HA-specific antibody Fig. 3 . Lack of neutralization, but inhibition of plaque growth, by LMBH6. MDCK cells were infected with X31 mixed with LMBH6 or an HIV gp120-specific MAb at the final concentrations indicated. Cells were overlaid with agarose-DMEM containing 2n5 µg/ml trypsin, LMBH6 or an HIV gp120-specific MAb (270) at the concentrations indicated (j) or no antibody (k). Plaques were fixed and stained as described in Methods. related drift variants. We reasoned that by rapidly presenting to the immune system BHA molecules differing mainly in the globular heads, cross-reactive memory B cells which were present after the first immunization might be reactivated before B cells specific for the new immunodominant regions were activated. Intranasal administration of antigen without the use of adjuvant was performed. We did not investigate whether this immunization method is indeed superior to other methods used to induce cross-reactive antibodies [such as repeated administration of purified influenza virus, sequential infection or immunization with drift variants, use of (different) adjuvants or other routes of administration (Vareckova et al., 1995 ; Tamura et al., 1992 Tamura et al., , 1994 ]. However, serum obtained just before fusion was highly cross-reactive, and supernatants of 15 of 32 polyclonal cell populations obtained after fusion showed cross-reactivity with A\Beijing\352\89 virus. Moreover, the two MAbs isolated so far turned out to be highly crossreactive, suggesting that the immunization method did induce high levels of cross-reactive antibodies. In comparison, the H1, H2 cross-reactive antibody C179 was isolated only after screening of several hundred monoclonal hybridoma cells (Okuno et al., 1994) .
The antibody LMBH6 was found to have the following unique properties : it is highly cross-reactive but nonneutralizing although it can inhibit fusion and the low-pHinduced conformational change ; it recognizes the membrane- . LMBH6 prevents the low-pH-induced conformational change of BHA. BHA was mixed with LMBH6 or HC73, the pH was decreased to 5 and mixtures were incubated for 10 min at 37 mC. Changes in conformation were investigated by trypsin or DTT treatment as described. Samples were separated by non-reducing 12n5 % PAGE followed by Western blotting. BHA was visualized using rabbit anti-BHA, followed by horseradish peroxidase-conjugated goat anti-rabbit antibody. The blot was developed using 600 µg/ml 3,3h-DAB tetrachloride, 0n03 % NiCl 2 , 0n3% H 2 O 2 in PBS.
proximal end of the native trimeric stalk structure ; and it binds preferentially to the mature cleaved HA. The carboxy-terminal end of HA " and the amino-terminal end of HA # are generated by proteolytic cleavage of a single biosynthetic precursor molecule. The amino-terminal end of HA # , the so-called ' fusion peptide ', is buried in the interior of the trimer and is approximately 2n2 nm apart form the carboxy-terminal end of HA "
, indicating a conformational rearrangement upon cleavage . This structural difference between the uncleaved and cleaved trimeric molecule is detected by LMBH6. Although binding to uncleaved MDCK-expressed HA could be demonstrated, binding was enhanced upon trypsin treatment. In addition, the preferential binding to cleaved HA was demonstrated using a recombinant HA ! (THA ! ) that can be solubilized by trypsin treatment and can be cleaved into HA " and HA # by bromelain. LMBH6 does not prevent infection of MDCK cells, suggesting that neither adsorption to the cell surface nor fusion of viral and endosomal membranes is inhibited. Nevertheless, LMBH6 inhibits HA mediated cell-cell fusion and the low-pHinduced conformational change of BHA. These three assays are quite different, and many unknown variables may exist. For example, in the cell-cell fusion assay two cell membranes, both containing HA, are fused, while during infection viral and endosomal membrane are fused ; in the cell-cell inhibition assay the pH is decreased rapidly, while during infection a gradual acidification takes place. The number of LMBH6 molecules needed to prevent the conformational change of one HA molecule and the exact number of HA trimers needed for A cross-reactive HA-specific antibody A cross-reactive HA-specific antibody P. Vanlandschoot and others P. Vanlandschoot and others fusion are not known. It is clear, however, from the results obtained with LMBH6 that one has to be very careful when interpreting the results of these different assays.
Addition of the MAb in a plaque assay overlay slows the growth of X31 virus. It remains unclear how the antibody interferes with replication. It is unlikely that plaque reduction is caused by inhibition of virus induced cell-cell fusion, because the low pH needed for this process does not occur. One possible explanation is reduced expression of HA at the cell surface and, as a result, reduced assembly of virions, as was demonstrated for an M2-specific MAb. The presence of this MAb resulted in reduced expression of M2 on the cell surface, probably caused by clustering of M2 molecules, followed by endocytosis (Hughey et al., 1995) . However, it has been reported that HA is neither endocytosed nor does it becomes associated with coated pits in the presence of antibodies (Lazarovits & Roth, 1988) . A second possible mechanism to slow the growth of virus could be antibody-induced crosslinking of HA, which could reduce incorporation of HA into virions by restricting the lateral mobility in the membrane. However, it remains uncertain whether antibody-induced cross-linking by LMBH6 occurs. The electron microscopy studies demonstrated binding of LMBH6 to the membraneproximal end of BHA. Binding of two MAbs was clearly visible, especially in the Fab vesicle-BHA-LMBH6 complexes. These electron microscopy studies suggest that binding of LMBH6 to membrane-bound HA could be difficult. As the epitope is very close to the membrane and binding occurs at an angle of 110 m, the flexibility needed for binding two HA molecules would be rather high. This inaccessibility of the epitope is supported by the different binding assays, demonstrating reduced or weaker binding of LMBH6 to membranebound viral and cell-expressed HA than to soluble BHA.
